| Group |
| |
P value | Preventive (N = 40) | Preemptive (N = 40) | |
|
|
| PONV incidence, frequency (%) |
0.769 | 6 (15) | 8 (20) | Recovery |
1.0 | 6 (15) | 5 (12.5) | 3 hours |
1.0 | 5 (12.5) | 5 (12.5) | 6 hours |
1.0 | 1 (2.5) | 2 (5) | 24 hours |
0.815 | 13 (32.5) | 15 (37.5) | Total |
|
|
| PONV score mean (SD) |
0.001* | 0.18 ± 0.07 | 0.28 ± 0.09 | Recovery |
0.975 | 0.2 ± 0.08 | 0.23 ± 0.08 | 3 hours |
0.238 | 0.2 ± 0.08 | 0.18 ± 0.07 | 6 hours |
0.043* | 0.06 ± 0.05 | 0.1 ± 0.07 | 24 hours |
0.023* | 0.63 ± 0.16 | 0.75 ± 0.18 | Total |
0.037* | 3 (7.5) | 11 (27.5) | Frequency of PONV ≥ 2 |
0.017* | 8.01 ± 3.14 | 6.42 ± 2.69 | The time of the first antiemetic request (hour) |
--- | 70 | 100 | Total antiemetic consumption (metoclopramide) (mg) |
0.001* | 1.75 ± 2.6 | 2.5 ± 0.32 | Antiemetic consumption mg/person |
0.001* | 23.75 ± 1.45 | 25.93 ± 1.90 | Recovery time (min) |
0.001* | 22.48 ± 0.41 | 24.11 ± 0.40 | Hospital stay (h) |